Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study – The Lancet Psychiatry

This study provides preliminary support for the safety and efficacy of psilocybinfor treatment-resistant depression and motivates further trials, with more rigorousdesigns, to better examine the therapeutic potential of this approach.

Source: Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study – The Lancet Psychiatry